BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 38140058)

  • 1. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review.
    Luo Y; Sun M; Tan L; Li T; Min L
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Nanotechnology-Based Strategies for Bone Tuberculosis Management.
    Luo Y; Chen H; Chen H; Xiu P; Zeng J; Song Y; Li T
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances of drug delivery nanocarriers in osteosarcoma treatment.
    Wang SY; Hu HZ; Qing XC; Zhang ZC; Shao ZW
    J Cancer; 2020; 11(1):69-82. PubMed ID: 31892974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies.
    Liang H; Cui M; Tu J; Chen X
    Front Cell Dev Biol; 2024; 12():1394339. PubMed ID: 38915446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
    Shi P; Cheng Z; Zhao K; Chen Y; Zhang A; Gan W; Zhang Y
    J Nanobiotechnology; 2023 Mar; 21(1):103. PubMed ID: 36944946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Tumour Metastasis: The Emerging Role of Nanotechnology.
    Visentin S; Sedić M; Pavelić SK; Pavelić K
    Curr Med Chem; 2020; 27(8):1367-1381. PubMed ID: 30569844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach.
    Santos A; Domingues C; Jarak I; Veiga F; Figueiras A
    Eur J Pharm Biopharm; 2022 Jan; 170():91-111. PubMed ID: 34896571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease.
    Ullah A; Ullah M; Lim SI
    Curr Probl Cardiol; 2024 Apr; 49(4):102396. PubMed ID: 38266693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview.
    Desai SA; Manjappa A; Khulbe P
    J Egypt Natl Canc Inst; 2021 Feb; 33(1):4. PubMed ID: 33555490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarrier-based drug delivery systems for bone cancer therapy: a review.
    Prasad SR; Kumar TSS; Jayakrishnan A
    Biomed Mater; 2021 May; 16(4):. PubMed ID: 33853043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
    Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma and Metastasis.
    Sheng G; Gao Y; Yang Y; Wu H
    Front Oncol; 2021; 11():780264. PubMed ID: 34956899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review.
    Jimmy R; Stern C; Lisy K; White S
    JBI Database System Rev Implement Rep; 2017 Aug; 15(8):2113-2152. PubMed ID: 28800058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.
    PosthumaDeBoer J; Witlox MA; Kaspers GJ; van Royen BJ
    Clin Exp Metastasis; 2011 Jun; 28(5):493-503. PubMed ID: 21461590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.
    Fan TM; Roberts RD; Lizardo MM
    Front Oncol; 2020; 10():13. PubMed ID: 32082995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Nano Drug Delivery System (NDDS) in Cancer Therapy: A Perspective.
    Liu J; Li S; Wang J; Li N; Zhou J; Chen H
    Recent Pat Anticancer Drug Discov; 2022; 18(2):125-132. PubMed ID: 35838209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin in human osteosarcoma: From analogs to carriers.
    Lu KH; Lu PW; Lin CW; Yang SF
    Drug Discov Today; 2023 Feb; 28(2):103437. PubMed ID: 36372327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology-Based Drug Delivery Systems for Honokiol: Enhancing Therapeutic Potential and Overcoming Limitations.
    Yang J; Shang J; Yang L; Wei D; Wang X; Deng Q; Zhong Z; Ye Y; Zhou M
    Int J Nanomedicine; 2023; 18():6639-6665. PubMed ID: 38026538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances of smart nano-drug delivery systems in osteosarcoma treatment.
    Liu Y; Li Q; Bai Q; Jiang W
    J Mater Chem B; 2021 Jul; 9(27):5439-5450. PubMed ID: 34155495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.